D&H National Research Centers is currently conducting a study on Lupus. As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.

Inclusion Criteria:

If you want to participate in this study, you must meet the following criteria:

​

• Male or female subjects aged from 18 to 75 years old (both inclusive).

• Diagnosis of SLE (Systemic lupus erythematosus )made at least 6 months prior to Screening.

• Musculoskeletal or mucocutaneous manifestations (i.e., myositis, arthritis, rash, alopecia, mucosal ulcers).

• Currently treated with one or more of the following SLE background medications:
  • Antimalarials, Mycophenolate mofetil, Azathioprine, Methotrexate, OCS or Belimumab.

Exclusion Criteria:

You are not eligible for participation in this study if:

• Pregnant or lactating women.

• Active severe SLE-driven renal disease.

• Severe forms of vasculitis requiring systemic immunosuppressive treatment.

• History or presence of severe respiratory disease or pulmonary fibrosis.

• Myocardial infarction, unstable angina pectoris, stroke, transient ischemic attack, vascular thrombosis, decompensated heart failure requiring hospitalization, or heart failure within 6 months prior to Screening.

• History or presence of severe respiratory disease or pulmonary fibrosis, Tuberculosis, Hepatitis A, B, C, HIV.

• History or presence of bone marrow or solid organ transplantation.

​